# Anthera Pharmaceuticals‚

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anthera-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: Hayward, US
- Website: www.anthera.com
- Total disclosed funding: $55M
- Latest round: Series B (Aug 13, 2008)
- Investors on record: 8

## About

Founded in 2004 and based in California, US, Anthera Pharmaceuticals‚ Inc. is a biopharmaceutical company that focuses on developing products for the treatment of serious and life-threatening diseases, including exocrine pancreatic insufficiency and B-cell associated renal diseases.

## Funding rounds

- Series B, Aug 13, 2008, $19M — Sofinnova Investments, VantagePoint Capital, HBM Partners, Pappas Capital, Valence Life Sciences, Mitsubishi Corporation
- Series A, Sep 13, 2006, $36M — Sofinnova Investments, VantagePoint Capital, Pappas Capital, Mitsubishi Corporation, Sears Capital Management, SIM Equity
- Series A, Apr 20, 2005 — Sears Capital Management, SIM Equity

## Investors

- Sears Capital Management (https://capitalatlas.ai/funds/sears-capital-management) — Series A
- SIM Equity — Series A
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A, Series B
- VantagePoint Capital (https://capitalatlas.ai/funds/vantagepoint-capital) — Series A, Series B
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series A, Series B
- Mitsubishi Corporation — Series A, Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series B
- Valence Life Sciences (https://capitalatlas.ai/funds/valence-life-sciences) — Series B